FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
Silvia Licciulli(European Institute of Oncology), Joseph L. Kissil(The Wistar Institute), Chun Zhou(Guangdong Pharmaceutical University), Jeffrey Field(University of Pennsylvania), David A. Campbell(Carleton University), Scott Troutman(Moffitt Cancer Center), Sergio G. Durón(Afraxis (United States)), Ronen Marmorstein(University of Pennsylvania), Qin Liu(University of Science and Technology of China), Jonathan Chernoff(Fox Chase Cancer Center), Smitha Kota(Scripps Research Institute), Jasna Maksimoska
Cited by 134
Related Papers
The Genome Sequence of <i>Trypanosoma cruzi</i> , Etiologic Agent of Chagas Disease
|Science|2005|1.4k
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|878
Acetylation of the p53 DNA-Binding Domain Regulates Apoptosis Induction
|Molecular Cell|2006|747
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
|Cold Spring Harbor Perspectives in Biology|2014|629